🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the bioequivalence of metformin co...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02221180
PF-06700841 is a dual Tyrosine kinase 2 (TYK2) Janus kinase 1 (JAK1) inhibi...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-01-07
Trial ID
NCT03765554
Treatments Being Tested
To demonstrate bioequivalence of a 2.5 mg saxagliptin/1000 mg metformin (gl...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00897390
Treatments Being Tested
The objectives of this study are (a) to determine if drug levels from a sin...
Status
Completed
Location
Pharmaceutical Research Unit
Start Date
2014-06
Trial ID
NCT02157649
The purpose of this study is to see how different forms of a medicine calle...
Status
Completed
Location
Pfizer Clinical Research Unit - New Haven
Start Date
2025-09-05
Trial ID
NCT07172321
Treatments Being Tested
A Phase 1, Partially-Blinded, Placebo-Controlled, Randomized, Multiple Asce...
Status
Completed
Location
TKL Research, Inc.
Start Date
2021-02-03
Trial ID
NCT04865536
Treatments Being Tested
The purpose of this study is to demonstrate the Bioequivalence, assess food...
Status
Completed
Location
Research Site
Start Date
2012-07
Trial ID
NCT01623609
The purpose of this study to evaluate the bioequivalence (is the amount sam...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02220218
This clinical trial is being conducted to compare concentrations of hydroco...
Status
Withdrawn
Location
US001: PRA Health Sciences
Start Date
2017-09
Trial ID
NCT03137030
Treatments Being Tested
To demonstrate bioequivalence of a 2.5 mg saxagliptin/500 mg metformin (glu...
Status
Completed
Location
Mds Pharma Services
Start Date
2009-06
Trial ID
NCT00899470